治疗性逆行胰胆管造影临床价值分析  

Analysis of clinical value of therapeutic endoscopic retrograde cholangiopancreatography

作　　者：吴汉平[1] 康生朝[1] 张方信[1] 王宏[1] 魏红梅[1] 贺月[1] 

机构地区：[1]兰州军区兰州总医院消化科,甘肃兰州730050

出　　处：《第四军医大学学报》2009年第6期552-554,共3页Journal of the Fourth Military Medical University

摘　　要：目的:探讨治疗性内镜逆行胰胆管造影术(ERCP)的临床应用价值及其相关并发症.方法:对2005-01/2008-07有胰胆疾病的302例患者进行ERCP治疗.收集临床资料进行全面统计,回顾性分析.结果:患者以老年比例最大.302例ERCP治疗总成功率为84.4%,其中前150例成功率为79.3%,后152例成功率为89.5%.并发症共11例,总体并发症发生率为3.6%.并发症均经内科保守治疗及内镜下治疗治愈,无外科手术及死亡病例.结论:治疗性ERCP是一项安全、有效的治疗技术.适用于多种胆胰疾病.操作成功率与术者的经验积累有密切关系.其并发症多数是可预防的,内科保守治疗联合内镜下治疗可治愈绝大多数并发症.AIM： To evaluate the clinical value and complications of therapeutic endoscopic retrograde eholangiopancreatography （ERCP）. METHODS： Three hundred and two cases with cholangiopanereatie diseases were treated with therapeutic ERCP technique in our center from January, 2005 to July, 2008. Clinical data of these cases were reviewed retrospectively. RESULTS ： Of the 302 cases, the final success rate was 84. 4% , among which the success rate of the first 150 cases was 79.3% arid the subsequent 152 cases was 89.5% respectively. Complications occurred in 11 cases （ overall complication rate was 3.6% ）. All the complications were cured with non-surgical as well as endoscopic treatments and no death occurred. CONCLUSION： ERCP is an effective and safe therapeutic approach and can be applied to most cholangiopancreatie diseases. The experience of endoscopists plays an important role in the success rate. Most of ERCP-related complications can be controlled by conservative as well as endoscopic treatments.

关 键 词：胰胆管造影术 内窥镜逆行 胆道疾病 胰腺疾病 治疗学 并发症 

分 类 号：R571[医药卫生—消化系统]